Skip to main content

Table 3 The change (>2-fold change, p < 0.05) of fibrosis-related genes in CLU KO kidneys compared to WT controls after 30 days of IRI

From: Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury

Gene (protein)

Fold change in KO kidneys vs. WT controls

p value (n = 4)

Main functions

Egf (Epidermal growth factor)

−2.7208

0.0341

The growth of epidermal and epithelial cells, and some of fibroblasts

ccl12 (Chemokine (C-C Motif) ligand 12)

2.1439

0.0130

The recruitment of monocytes, lymphocytes and fibrocytes

col3a1 (Collagen, Type III, alpha 1)

2.0162

0.0457

Fibril forming

mmp9 (Matrix metallopeptidase 9)

2.573

0.0132

The degradation of the extracellular matrix

timp1 (Tissue inhibitor of metalloproteinase 1)

2.0831

0.0260

Inhibition of the matrix metalloproteinases

  1. Four renal tissues (cortex) were randomly selected from each group for PCR array analysis of gene expression using mouse fibrosis PCR array (Catalog No. PAMM-120Z). Negative in fold change: down-regulated; positive in fold change: up-regulated